Skip to content
  • Sunday, 26 July 2026
  • 4:38 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • TWiV 1288: Clinical Update with Dr. Daniel Griffin Examines Alarming Shifts in Vaccine Policy and Ongoing Public Health Challenges
Microbiology & Immunology

TWiV 1288: Clinical Update with Dr. Daniel Griffin Examines Alarming Shifts in Vaccine Policy and Ongoing Public Health Challenges

Lina Irawan Jun 22, 2026 0

In a recent clinical update, Dr. Daniel Griffin and Vincent Racaniello of This Week in Virology (TWiV) expressed profound concern…

Read More
Microbiology & Immunology

TWiV 1290: Clinical update with Dr. Daniel Griffin

Lina Irawan Jun 21, 2026 0

In a comprehensive clinical update shared on the "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin, a seasoned clinician…

Read More
Microbiology & Immunology

TWiV 1292: Clinical update with Dr. Daniel Griffin

Lina Irawan Jun 21, 2026 0

In a stark assessment of the current state of public health in the United States, Dr. Daniel Griffin, a seasoned…

Read More
Microbiology & Immunology

TWiV 1284: Clinical update with Dr. Daniel Griffin

Lina Irawan Jun 15, 2026 0

In a timely post-New Year’s Day discussion, This Week in Virology (TWiV) episode 1284 features Dr. Daniel Griffin, a practicing…

Read More
Microbiology & Immunology

TWiV 1286: Clinical Update with Dr. Daniel Griffin Addresses Alarming Shifts in Public Health Discourse and Data

Lina Irawan Jun 15, 2026 0

In a recent episode of "This Week in Virology" (TWiV), Dr. Daniel Griffin, alongside host Vincent Racaniello, expressed profound bewilderment…

Read More
Microbiology & Immunology

TWiV 1288: Clinical update with Dr. Daniel Griffin

Lina Irawan Jun 14, 2026 0

In a recent clinical update, Dr. Daniel Griffin, alongside Vincent Racaniello, expressed profound bewilderment and dismay regarding announced changes to…

Read More
Microbiology & Immunology

TWiV 1290: Clinical Update with Dr. Daniel Griffin Delves into Infectious Disease Trends and Public Health Strategies

Lina Irawan Jun 14, 2026 0

In his latest clinical update on "This Week in Virology" (TWiV) episode 1290, Dr. Daniel Griffin provided a comprehensive overview…

Read More
Microbiology & Immunology

TWiV 1292: Clinical update with Dr. Daniel Griffin

Lina Irawan Jun 13, 2026 0

The recent weekly clinical update on "This Week in Virology" (TWiV) podcast, hosted by Vincent Racaniello and featuring Dr. Daniel…

Read More
Microbiology & Immunology

TWiV 1292: Clinical update with Dr. Daniel Griffin

Lina Irawan Jun 6, 2026 0

The latest clinical update from the popular "This Week in Virology" (TWiV) podcast, episode 1292, hosted by Vincent Racaniello and…

Read More
Microbiology & Immunology

TWiV 1292: Clinical update with Dr. Daniel Griffin

Lina Irawan Jun 2, 2026 0

In a somber weekly clinical update on "This Week in Virology" (TWiV) podcast episode 1292, Dr. Daniel Griffin and Vincent…

Read More

Posts pagination

1 2 3 4 … 9
Salk Institute Researchers Identify BCL6 Protein as Critical Factor in Preventing Muscle Loss During Weight Loss and AgingBiogen Acquires RayThera for Up to $1 Billion to Bolster Immunology PipelineArtificial Intelligence Decodes the Molecular Mystery of Supercooled Water StructureUnconscious Brain Processes Language and Predicts Speech During General Anesthesia According to New Baylor Study
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ